Shea Jacqueline Elizabeth

Shea Jacqueline Elizabeth is listed in filings as Chief Executive Officer at Inovio Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including 24 public disclosures. Recent filings connect the profile to Inovio Pharmaceuticals, Inc. (INO). The current snapshot covers public activity from Feb 28, 2025 to May 21, 2026. Reported amounts are shown as $214.1K to $10.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.